Search Results - "Kibuuka, Laura N."

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Direct visualization of CHIP-mediated degradation of alpha-synuclein in vivo: implications for PD therapeutics

    Direct visualization of CHIP-mediated degradation of alpha-synuclein in vivo: implications for PD therapeutics by Dimant, Hemi, Zhu, Liya, Kibuuka, Laura N, Fan, Zhanyun, Hyman, Bradley T, McLean, Pamela J

    Published in PloS one (24-03-2014)
    “…Parkinson's disease is a neurodegenerative disorder characterized by Lewy bodies, a pathological hallmark comprised mostly of aggregated alpha synuclein…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Abnormal involuntary movement (AIM) expression following D2 dopamine agonist challenge is determined by the nature of prior dopamine receptor stimulation (priming) in 6-hydroxydopamine lesioned rats

    Abnormal involuntary movement (AIM) expression following D2 dopamine agonist challenge is determined by the nature of prior dopamine receptor stimulation (priming) in 6-hydroxydopamine lesioned rats by Drake, Jonathan D., Kibuuka, Laura N., Dimitrov, Kroum D., Pollack, Alexia E.

    Published in Pharmacology, biochemistry and behavior (01-04-2013)
    “…Rats with unilateral 6-hydroxydopamine (6-OHDA) lesions show sensitization (priming) of rotational behavior upon repeated treatment with dopamine agonists. To…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: